Skip to content
DraconiticResearch
Search Sources API
224,303 studies31 sourcesUpdated 39 min ago
Peer-reviewedCC BY-NC-ND 4.0Systematic Reviews

Gynecological complications following allogeneic hematopoietic cell transplantation and clinical management recommendations: a scoping review protocol

  • Cheick K. Koanda1
  • Coralie Michaud2
  • Jean Roy3,4
  • Laurence Simard-Émond2,5
  • Deana Funaro6
  • Marie-Hélène Mayrand1,2
  • Claudie Laprise1,5,7
7 affiliations
  1. 1Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, Quebec Canada
  2. 2Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Quebec Canada
  3. 3Division of Hematology, Oncology and Transplantation, Hôpital Maisonneuve-Rosemont Research Centre, Montreal, QC Canada
  4. 4Départment of Medicine, Université de Montréal, Montreal, Quebec Canada
  5. 5Centre Hospitalier de l’Université de Montréal Research Centre, Montreal, QC Canada
  6. 6Départment of Dermatology, Université de Montréal, Montreal, Quebec Canada
  7. 7Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec Canada
Read full textDOICite

Abstract

Background: Allogeneic hematopoietic cell transplantation (HCT) has become a curative treatment option for many hematological disorders. However, female recipients face unique challenges related to their reproductive and gynecological health that are often overlooked in clinical practice and research. Despite the growing recognition of sex and gender considerations in transplantation medicine, there remains a significant gap in data to devise comprehensive guidelines addressing gynecological health concerns specifically following allogeneic HCT. These complications can significantly impact quality of life, fertility, sexual function, and long-term health outcomes.

Methods: We will conduct a scoping review to map and synthesize the available evidence on gynecological health concerns following allogeneic HCT and their clinical management. Our review will include female recipients of allogeneic HCT ≥ 18 years old. We will search MEDLINE, Embase, CINAHL, and the APA PsycINFO for relevant literature without date or language restrictions. Additionally, we will search gray literature sources including clinical trial registries and transplantation and gynecological society guidelines. Two reviewers will independently evaluate the eligibility of all identified titles and abstracts for inclusion in the full text review, as well as data extraction. Data extraction will focus on types of gynecological complications, their prevalence or incidence, and identified risk factors, screening and treatment approaches, clinical outcomes, and management recommendations. Descriptive statistics and narrative synthesis will be used to analyze and present the findings.

Discussion: This scoping review will consolidate the current knowledge on gynecological health concerns following allogeneic HCT and identify best practices for their management. Our findings will highlight critical gaps in current medical literature and practice, paving the way to inform the development of evidence-based clinical management recommendations for female allogeneic HCT recipients. By addressing this understudied aspect of transplantation medicine, our review aims to improve overall health, enhance quality of life, and ensure comprehensive personalized care for women undergoing HCT.

Systematic review registration: https://doi.org/10.17605/OSF.IO/5NPJF

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13643-026-03283-x.

Related

  1. Syndrome-oriented CNS infectious complications after hematopoietic stem-cell transplantation and CAR T-cell therapy, part 1—viral encephalitis, meningitis, and myelitis: recommendations from the Practice Harmonization & Guidelines Committee of the EBMT
    José Luis Piñana, Simone Cesaro, Jan Styczynski +12
    eClinicalMedicinePeer-reviewedCC BY 4.0General medicineCrossref
  2. EARLY INFECTIOUS COMPLICATIONS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: PATHOGEN SPECTRUM, PRETRANSPLANT COLONIZATION CONCORDANCE, AND 100-DAY MORTALITY IN A SINGLE-CENTRE COHORT
    Evgeniia ZHELNOVA, Leonid KHORDZHASOV, Ekaterina KARIMOVA +1
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  3. The role of allogeneic hematopoietic stem cell transplantation in adults with mature T‐cell lymphomas
    Laura Diana Stocker, Lisa Thielecke, Constantin Schmitz +3
    The Cochrane Database of Systematic ReviewsPeer-reviewedPublisher termsFull textGeneral medicinePMC
  4. Case Report: SAPHO syndrome mimicking osseous relapse after haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
    Wenhui Zhang, Xiaolin Ma, Xianglan Liu +6
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Viral Respiratory Infections Diagnosed by Multiplex PCR after Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Incidence and Outcome
    Alice Wolfromm, Raphael Porcher, Jérome Legoff +7
    Biology of Blood and Marrow TransplantationPeer-reviewedCC BY-NC-NDFull text40 citedEpidemiology & public healthHAL

Cite

BibTeXRIS
BibTeX
@article{koanda2026gynecological,
  title = {{Gynecological complications following allogeneic hematopoietic cell transplantation and clinical management recommendations: a scoping review protocol}},
  author = {Cheick K. Koanda and Coralie Michaud and Jean Roy and Laurence Simard-Émond and Deana Funaro and Marie-Hélène Mayrand and Claudie Laprise},
  journal = {Systematic Reviews},
  year = {2026},
  month = aug,
  doi = {10.1186/s13643-026-03283-x},
  url = {https://doi.org/10.1186/s13643-026-03283-x},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Gynecological complications following allogeneic hematopoietic cell transplantation and clinical management recommendations: a scoping review protocol
AU  - Cheick K. Koanda
AU  - Coralie Michaud
AU  - Jean Roy
AU  - Laurence Simard-Émond
AU  - Deana Funaro
AU  - Marie-Hélène Mayrand
AU  - Claudie Laprise
PY  - 2026
DA  - 2026/08/11
JO  - Systematic Reviews
DO  - 10.1186/s13643-026-03283-x
UR  - https://doi.org/10.1186/s13643-026-03283-x
AB  - Background: Allogeneic hematopoietic cell transplantation (HCT) has become a curative treatment option for many hematological disorders. However, female recipients face unique challenges related to their reproductive and gynecological health that are often overlooked in clinical practice and research. Despite the growing recognition of sex and gender considerations in transplantation medicine, there remains a significant gap in data to devise comprehensive guidelines addressing gynecological health concerns specifically following allogeneic HCT. These complications can significantly impact quality of life, fertility, sexual function, and long-term health outcomes.  Methods: We will conduct a scoping review to map and synthesize the available evidence on gynecological health concerns following allogeneic HCT and their clinical management. Our review will include female recipients of allogeneic HCT ≥ 18 years old. We will search MEDLINE, Embase, CINAHL, and the APA PsycINFO for relevant literature without date or language restrictions. Additionally, we will search gray literature sources including clinical trial registries and transplantation and gynecological society guidelines. Two reviewers will independently evaluate the eligibility of all identified titles and abstracts for inclusion in the full text review, as well as data extraction. Data extraction will focus on types of gynecological complications, their prevalence or incidence, and identified risk factors, screening and treatment approaches, clinical outcomes, and management recommendations. Descriptive statistics and narrative synthesis will be used to analyze and present the findings.  Discussion: This scoping review will consolidate the current knowledge on gynecological health concerns following allogeneic HCT and identify best practices for their management. Our findings will highlight critical gaps in current medical literature and practice, paving the way to inform the development of evidence-based clinical management recommendations for female allogeneic HCT recipients. By addressing this understudied aspect of transplantation medicine, our review aims to improve overall health, enhance quality of life, and ensure comprehensive personalized care for women undergoing HCT.  Systematic review registration: https://doi.org/10.17605/OSF.IO/5NPJF  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13643-026-03283-x.
SN  - 2046-4053
ER  -